Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Further investigations on the antiinflammatory effect of rutaecarpine

Jan. 13, 2000

Alpha4-selective integrin antagonists in the Celltech pipeline

Jan. 12, 2000

Rat adjuvant arthritis ameliorated by thalidomide analogue

Jan. 10, 2000

The antiplatelet agent triflusal now shown to inhibit NF-kappaB activation

Jan. 10, 2000

Orally active, selective iNOS inhibitors discovered at Glaxo Wellcome

Jan. 6, 2000

Imidazole cytokine inhibitors in the pipeline at SmithKline Beecham

Jan. 6, 2000

RWJ-67657 undergoes further study based on favorable preliminary biological profile

Jan. 5, 2000

Addition of infliximab to methotrexate therapy reduces RA symptoms

Jan. 5, 2000

SmithKline Beecham patents novel ERK/MAP kinase inhibitors

Jan. 3, 2000

Phenylalanine derivatives selective for alpha4 integrins discovered by Celltech

Jan. 3, 2000

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...